📰 Modius Stress News
Modius Stress News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Modius Stress. Real-time updates on events, politics, business and more.
June 6, 2024
Neurovalens, a global leader in non-invasive neuro-technology, has appointed Kate Willis to oversee the sales of the belfast firms prescribed medical devices in the US
April 24, 2024
Neurovalens Ltd recently received U.S. FDA clearance for its Modius Stress device, a neurostimulator that treats people suffering from generalized anxiety disorder (GAD). It also closed a £2.1 million (US$2.65 million) funding round and is planning to raise up to $50 million in a series B fundraising round to be launched later this year.
April 23, 2024
The FDA has cleared Modius Stress, a medical device for the treatment of anxiety.
April 12, 2024
The FDA has cleared Modius Stress, a medical device for the treatment of anxiety.
April 8, 2024
Neurovalens announced today that it received FDA clearance for its Modius Stress device for treating anxiety and raised $2.65 million.
April 8, 2024
Modius Stress headset delivers electrical pulses to the brain and nervous system
April 8, 2024
Healthtech firm received FDA clearance in October for an anti-insomnia device and has approvals pending for the treatment of PTSD and obesity
April 8, 2024
A health tech firm in Belfast has received medical device clearance in the US for a headset adapted to treat anxiety.